Literature DB >> 27174400

Accelerated leukocyte telomere erosion in schizophrenia: Evidence from the present study and a meta-analysis.

Shuquan Rao1, Lakshmi Narayanan Kota2, Zongchang Li3, Yao Yao4, Jinsong Tang3, Canquan Mao5, Sanjeev Jain2, Yong Xu6, Qi Xu7.   

Abstract

Human telomeres consist of tandem nucleotide repeats (TTAGGG) and associated proteins, and telomere length (TL) is reduced progressively with cell division over the lifespan. Telomere erosion might be accelerated or prevented to varying degrees when exposure to serious medical illnesses. In previous studies, an association between TL decrease and schizophrenia has been extensively reported; however, the results remain largely controversial. To further investigate TL in schizophrenia patients and reconcile this controversy, we first measured leucocyte TL (LTL) in our samples (52 paranoid schizophrenia, 89 non-paranoid patients and 120 controls), and then conducted a comprehensive meta-analysis of the existing results of LTL in patients of schizophrenia compared to healthy subjects. Totally, 11 studies encompassing 1243 patients of schizophrenia and 1274 controls were included in the final meta-analysis model. In our samples, significant reduction of LTL in paranoid schizophrenia was observed compared to controls (F = 50.88, P < 0.001); whereas there was no significant difference in LTL between non-paranoid schizophrenia and controls (F = 0.842, P = 0.360). For meta-analysis, random-effects model showed significant LTL decrease in patients of schizophrenia when compared to controls (Z = 2.07, P = 0.039, SMD = -0.48, 95% CI = -0.94 to -0.03). Moreover, a marginal decrease in LTL was observed in medicated patients (Z = 1.92, P = 0.055, SMD = -0.58, 95% CI = -1.18-0.01) and those patients with poor response to antipsychotics (Z = 1.76, P = 0.078, SMD = -0.60, 95% CI = -1.27-0.07). In conclusion, we observed significant reduction of LTL in individuals with schizophrenia compared with controls. However, all the studies included in the meta-analysis were cross-sectional, and better controlled long-term studies are needed to replicate this result.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disease status; Meta-analysis; Paranoid; Schizophrenia; Telomere length

Mesh:

Year:  2016        PMID: 27174400     DOI: 10.1016/j.jpsychires.2016.04.010

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  11 in total

Review 1.  Accelerating research on biological aging and mental health: Current challenges and future directions.

Authors:  Laura K M Han; Josine E Verhoeven; Audrey R Tyrka; Brenda W J H Penninx; Owen M Wolkowitz; Kristoffer N T Månsson; Daniel Lindqvist; Marco P Boks; Dóra Révész; Synthia H Mellon; Martin Picard
Journal:  Psychoneuroendocrinology       Date:  2019-04-05       Impact factor: 4.905

2.  Mental Disorders Are Associated With Leukocytes Telomere Shortening Among People Who Inject Drugs.

Authors:  Mélusine Durand; Nicolas Nagot; Laurent Michel; Sao Mai Le; Huong Thi Duong; Roselyne Vallo; Amélie Vizeneux; Delphine Rapoud; Hoang Thi Giang; Catherine Quillet; Nham Thi Tuyet Thanh; Khuat Thi Hai Oanh; Vu Hai Vinh; Jonathan Feelemyer; Philippe Vande Perre; Khue Pham Minh; Didier Laureillard; Don Des Jarlais; Jean-Pierre Molès
Journal:  Front Psychiatry       Date:  2022-06-17       Impact factor: 5.435

3.  Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications.

Authors:  Alessio Squassina; Mirko Manchia; Claudia Pisanu; Raffaella Ardau; Carlo Arzedi; Alberto Bocchetta; Paola Caria; Cristina Cocco; Donatella Congiu; Eleonora Cossu; Tinuccia Dettori; Daniela Virginia Frau; Mario Garzilli; Elias Manca; Anna Meloni; Maria Antonietta Montis; Andrea Mura; Mariella Nieddu; Barbara Noli; Pasquale Paribello; Federica Pinna; Renato Robledo; Giovanni Severino; Valeria Sogos; Maria Del Zompo; Gian Luca Ferri; Caterina Chillotti; Roberta Vanni; Bernardo Carpiniello
Journal:  Neuropsychopharmacology       Date:  2020-09-12       Impact factor: 7.853

4.  Common mental disorders and association with telomere length.

Authors:  E Vakonaki; K Tsiminikaki; S Plaitis; P Fragkiadaki; D Tsoukalas; I Katsikantami; G Vaki; M N Tzatzarakis; D A Spandidos; A M Tsatsakis
Journal:  Biomed Rep       Date:  2018-01-08

5.  Common Variants in OPG Confer Risk to Bone Mineral Density Variation and Osteoporosis Fractures.

Authors:  Xiaoyong Sheng; Guangyong Cai; Xingjun Gong; Zouying Yao; Ye Zhu
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

6.  Telomere length as a predictor of emotional processing in the brain.

Authors:  Timothy R Powell; Simone De Jong; Gerome Breen; Cathryn M Lewis; Danai Dima
Journal:  Hum Brain Mapp       Date:  2018-12-04       Impact factor: 5.038

7.  Telomere length and early trauma in schizophrenia.

Authors:  Gabriella Riley; Mary Perrin; Leila M Vaez-Azizi; Eugene Ruby; Raymond R Goetz; Roberta Dracxler; Julie Walsh-Messinger; David L Keefe; Peter F Buckley; Philip R Szeszko; Dolores Malaspina
Journal:  Schizophr Res       Date:  2018-04-02       Impact factor: 4.939

8.  Telomeres as integrative markers of exposure to stress and adversity: a systematic review and meta-analysis.

Authors:  Gillian V Pepper; Melissa Bateson; Daniel Nettle
Journal:  R Soc Open Sci       Date:  2018-08-29       Impact factor: 2.963

Review 9.  Early Senescence and Leukocyte Telomere Shortening in SCHIZOPHRENIA: A Role for Cytomegalovirus Infection?

Authors:  Corona Solana; Diana Pereira; Raquel Tarazona
Journal:  Brain Sci       Date:  2018-10-18

10.  Controlling for baseline telomere length biases estimates of the rate of telomere attrition.

Authors:  Melissa Bateson; Dan T A Eisenberg; Daniel Nettle
Journal:  R Soc Open Sci       Date:  2019-10-30       Impact factor: 2.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.